ClinicalTrials.Veeva

Menu

S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma (WBS)

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Spinal Cord Injury

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.

Enrollment

60 patients

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • vertebral fracture
  • injuries to the vertebral spine

Exclusion criteria

  • head trauma
  • polytrauma

Trial design

60 participants in 2 patient groups

1
Description:
patients with neurological symptoms
2
Description:
patients without neurological symptoms

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems